+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner



5-HT2A receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner



Brain Research 947(2): 157-165, 30 August



Combined serotonin (5-HT)(2A) and dopamine (DA) D(2) blockade has been shown to contribute to the ability of atypical antipsychotic drugs (APDs) to increase DA release in rat medial prefrontal cortex (mPFC). We provide additional support for this hypothesis by examining the effect of the selective 5-HT(2A) antagonist M100907 plus haloperidol, a potent D(2) antagonist APD, on DA release in the mPFC and nucleus accumbens (NAC). Haloperidol (0.01-1.0 mg/kg) produced an inverted U-shaped increase in DA release in the mPFC, with a significant increase only at 0.1 mg/kg. Haloperidol (0.1 and 1.0 mg/kg) significantly increased DA release in the NAC. M100907 (0.1 mg/kg) by itself had no effect on DA release in either region. This dose of M100907 potentiated the ability of low (0.01-0.1 mg/kg), but not high dose (0.3-1.0 mg/kg) haloperidol to increase mPFC DA release, whereas it abolished the effect of both 0.1 and 1.0 mg/kg haloperidol on NAC DA release. These results suggest that the relatively higher ratio of 5-HT(2A) to D(2) antagonism may contribute to the potentiation of haloperidol-induced mPFC DA release, whereas 5-HT(2A) antagonism can diminish haloperidol-induced NAC DA release, even when combined with extensive D(2) antagonism, which may not be synergistic with 5-HT(2A) antagonism in the mPFC.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010043474

Download citation: RISBibTeXText

PMID: 12176156

DOI: 10.1016/s0006-8993(02)02620-3


Related references

M100907, a 5-HT2A receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex, but inhibits that in the nucleus accumbens. Society for Neuroscience Abstracts 26(1-2): Abstract No -143 15, 2000

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Psychopharmacology 183(2): 144-153, 2005

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Research 972(1-2): 216-221, 2003

Effect of AC - 260186, a 5 - HT2A/2C receptor antagonist, on haloperidol - induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 891 16, 2003

SR46349B, a 5-HT2 receptor antagonist, potentiates haloperidol -induced dopamine release in the medial prefrontal cortex and nucleus accumbens. Society for Neuroscience Abstracts 27(1): 1261, 2001

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Neuropsychopharmacology 27(3): 430-441, 2002

Valproic acid , an anticonvulsant mood stabilizer, potentiates antipsychotic drugs -induced dopamine release in rat medial prefrontal cortex but not nucleus accumbens. Society for Neuroscience Abstracts 27(1): 1261, 2001

Effects of medial prefrontal cortex dopamine antagonism on nucleus accumbens dopamine release and motor activity in the rat. Society for Neuroscience Abstracts 20(1-2): 823, 1994

R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum. Journal of Pharmacology and Experimental Therapeutics 291(3): 1227-1232, 1999

Basolateral amygdala dopamine modulation of stress-induced dopamine release in the nucleus accumbens and medial prefrontal cortex. Shinnick-Gallagher, Patricia , Reprint Author, Pitkanen, Asla, Shekhar, Anantha, Cahill, Larry The amygdala in brain function: Basic and clinical approaches: 549-551, 2003

5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Research 1134(1): 70-78, 2007

Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens. Brain Research 958(1): 176-184, 20 December, 2002

Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Neuropharmacology 56(2): 507-513, 2008